학술논문
Phase 1/2 Open-label Dose Evaluation Study of AXO-Lenti-PD Gene Therapy for Parkinson's Disease: Efficacy, Safety, and Tolerability Data up to 24 Months
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15577422